Latest news with #CarlaGoulartPeron
Yahoo
4 hours ago
- Health
- Yahoo
Philips to deploy image-guided therapy systems across Indonesia
Health technology company Royal Philips has joined forces with Indonesia's Ministry of Health to implement image-guided therapy systems across the country. This endeavour is part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, which aims to boost treatment for heart disease, stroke, and cancer. Royal Philips CEO Roy Jakobs said: "Delivering better care for more people requires strong partnerships and the best innovations. 'We're honoured to be Indonesia's partner of choice to deliver our innovation directly where it's needed most. More patients in Indonesia will now have access to better care.' The agreements, resulting from an international bidding process, encompass treatment technology, services, and training to fortify the health infrastructure of Indonesia. Funded by the World Bank and other multilateral development banks, the SIHREN project supports the health transformation agenda of the country by enhancing referral healthcare services. The project is set to increase access to minimally invasive treatments in hundreds of hospitals throughout 38 provinces, developing a network of image-guided therapy rooms. The Indonesian Ministry of Health is focused on providing nationwide coverage of the Azurion platform, tailored to the requirements of local hospital infrastructures and patient populations. Philips' chief medical officer Carla Goulart Peron said: 'Minimally invasive care is life-changing for patients, unlocking treatment options that were once unimaginable. With small incisions, such targeted treatments can mean shorter hospital stays, fewer complications and quicker recoveries for patients. 'From opening heart-attack-causing blockages, to treating strokes and targeting cancer tumours, image-guided, minimally invasive therapy will be a game-changer for NCD [non-communicable diseases] care in Indonesia.' Philips has more than 3,900 employees in 12 Indonesian cities and operates a manufacturing facility in Batam for its Personal Health businesses. Recently, the Philips Foundation collaborated with World Child Cancer to promote early detection of childhood cancers in Indonesia. Philips Indonesia president director Astri R Dharmawan said: 'We remain committed to supporting healthcare transformation by delivering innovations that provide better outcomes for patients and improve the experience for healthcare workers. 'Our combined efforts with the Indonesian government will help close healthcare gaps and bring us closer to a Healthy Indonesia.' In October 2024, Philips collaborated with Indonesia's Siloam Hospitals Group to accelerate AI capabilities and advance the country's healthcare sector. "Philips to deploy image-guided therapy systems across Indonesia" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hamilton Spectator
15-05-2025
- Health
- Hamilton Spectator
Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now
May 15, 2025 AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impact Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has released its 10th annual Future Health Index (FHI) report , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. However, gaps in trust threaten to stall progress at a time when innovation is most needed. 'The need to transform healthcare delivery has never been more urgent,' said Carla Goulart Peron , M.D., Chief Medical Officer at Philips. 'In more than half of the 16 countries surveyed, patients are waiting nearly two months or more for specialist appointments, with waits in Canada and Spain extending to four months or longer. As healthcare systems face mounting pressures, AI is rapidly emerging as a powerful ally, offering unprecedented opportunities to transform care and overcome today's toughest challenges.' Long waits, worsening outcomes The FHI 2025 report reveals 33% of patients have experienced worsening health due to delays in seeing a doctor, and more than 1 in 4 end up in the hospital due to long wait times. 'Cardiac patients face especially dangerous delays, with 31% being hospitalized before even seeing a specialist. Without urgent action, a projected shortfall of 11 million health workers by 2030 could leave millions without timely care,' Dr. Peron added. Clinician burnout and data burdens call for digital relief More than 75% of healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, with one-third losing over 45 minutes per shift, adding up to 23 full days a year lost by each professional. 'These inefficiencies amplify stress on already understaffed teams and contribute to burnout,' said Gretchen Brown, RN, VP and Chief Nursing Information Officer at Stanford Health Care. 'Recognizing this, as clinicians, we see AI as a solution and understand that delayed adoption can also carry major risks.' Of the nearly 2,000 healthcare professionals surveyed, if AI is not implemented: Trust gaps remain the biggest barrier to widespread AI adoption While clinicians are generally optimistic, the FHI 2025 report highlights a significant trust gap with patients – 34% more clinicians see AI's benefits than patients do, with optimism especially lower among patients aged 45 and older. Even among clinicians, skepticism remains: 69% are involved in AI and digital technology development, but only 38% believe these tools meet real-world needs. Concerns around accountability persist, with over 75% unclear about liability for AI-driven errors. Data bias is another major worry, as it risks deepening healthcare disparities if left unaddressed. 'To build trust with clinicians, we need education, transparency in decision-making, rigorous validation of models, and the involvement of healthcare professionals in every step of the process,' Brown added. The path forward: human-centric AI integration Patients want AI to work safely and effectively, reducing errors, improving outcomes, and enabling more personalized, compassionate care. Clinicians say trust hinges on clear legal and ethical standards, strong scientific validation, and continuous oversight. As AI reshapes healthcare, building trust is essential to delivering life-saving innovation faster and at scale. 'To realize the full potential of AI, regulatory frameworks must evolve to balance rapid innovation with robust safeguards to ensure patient safety and foster trust among clinicians,' said Shez Partovi , Chief Innovation Officer at Philips. 'By 2030, AI could transform healthcare by automating administrative tasks, potentially doubling patient capacity as AI agents assist, learn, and adapt alongside clinicians. To that end, we must design AI with people at the center—built in collaboration with clinicians, focused on safety, fairness, and representation—to earn trust and deliver real impact in patient care.' About the Future Health Index 2025 The Future Health Index is the largest global survey of its kind, analyzing the priorities and perspectives of healthcare professionals and patients across multiple countries. The Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care to more people. For more information, or to download the full FHI 2025 Global Report, visit . For further information, please contact: Kathy O'Reilly Philips Global External Relations Tel.: +1 978-807-1449 E-mail: About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at . Attachments
Yahoo
15-05-2025
- Health
- Yahoo
Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now
Family members A healthcare professional and their patient in discussion May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. However, gaps in trust threaten to stall progress at a time when innovation is most needed.'The need to transform healthcare delivery has never been more urgent,' said Carla Goulart Peron, M.D., Chief Medical Officer at Philips. 'In more than half of the 16 countries surveyed, patients are waiting nearly two months or more for specialist appointments, with waits in Canada and Spain extending to four months or longer. As healthcare systems face mounting pressures, AI is rapidly emerging as a powerful ally, offering unprecedented opportunities to transform care and overcome today's toughest challenges.'Long waits, worsening outcomesThe FHI 2025 report reveals 33% of patients have experienced worsening health due to delays in seeing a doctor, and more than 1 in 4 end up in the hospital due to long wait times. 'Cardiac patients face especially dangerous delays, with 31% being hospitalized before even seeing a specialist. Without urgent action, a projected shortfall of 11 million health workers by 2030 could leave millions without timely care,' Dr. Peron burnout and data burdens call for digital reliefMore than 75% of healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, with one-third losing over 45 minutes per shift, adding up to 23 full days a year lost by each professional. 'These inefficiencies amplify stress on already understaffed teams and contribute to burnout,' said Gretchen Brown, RN, VP and Chief Nursing Information Officer at Stanford Health Care. 'Recognizing this, as clinicians, we see AI as a solution and understand that delayed adoption can also carry major risks.' Of the nearly 2,000 healthcare professionals surveyed, if AI is not implemented: 46% fear missed opportunities for early diagnosis and intervention 46% cite growing burnout from non-clinical tasks 42% worry about an expanding patient backlog Trust gaps remain the biggest barrier to widespread AI adoptionWhile clinicians are generally optimistic, the FHI 2025 report highlights a significant trust gap with patients – 34% more clinicians see AI's benefits than patients do, with optimism especially lower among patients aged 45 and older. Even among clinicians, skepticism remains: 69% are involved in AI and digital technology development, but only 38% believe these tools meet real-world needs. Concerns around accountability persist, with over 75% unclear about liability for AI-driven errors. Data bias is another major worry, as it risks deepening healthcare disparities if left unaddressed. 'To build trust with clinicians, we need education, transparency in decision-making, rigorous validation of models, and the involvement of healthcare professionals in every step of the process,' Brown added. The path forward: human-centric AI integrationPatients want AI to work safely and effectively, reducing errors, improving outcomes, and enabling more personalized, compassionate care. Clinicians say trust hinges on clear legal and ethical standards, strong scientific validation, and continuous oversight. As AI reshapes healthcare, building trust is essential to delivering life-saving innovation faster and at scale.'To realize the full potential of AI, regulatory frameworks must evolve to balance rapid innovation with robust safeguards to ensure patient safety and foster trust among clinicians,' said Shez Partovi, Chief Innovation Officer at Philips. 'By 2030, AI could transform healthcare by automating administrative tasks, potentially doubling patient capacity as AI agents assist, learn, and adapt alongside clinicians. To that end, we must design AI with people at the center—built in collaboration with clinicians, focused on safety, fairness, and representation—to earn trust and deliver real impact in patient care.'About the Future Health Index 2025The Future Health Index is the largest global survey of its kind, analyzing the priorities and perspectives of healthcare professionals and patients across multiple countries. The Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care to more people. For more information, or to download the full FHI 2025 Global Report, visit For further information, please contact:Kathy O'ReillyPhilips Global External RelationsTel.: +1 978-807-1449E-mail: About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at Attachments FHI 2025 Global Report Infographic Family members A healthcare professional and their patient in discussionError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
